A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance (DOI:10.1016/j.cmet.2009.02.002);A Branched-Chain Amino Acid-Related Metabolic Signature that Differentiates Obese and Lean Humans and Contributes to Insulin Resistance

Cell Metabolism

Volumn 9, Issue 4, 2009, Pages 311-326

  Newgard, Christopher B ^a   An, Jie ^a   Bain, James R ^a   Muehlbauer, Michael J ^a   Stevens, Robert D ^a   Lien, Lillian F ^a   Haqq, Andrea M ^a   Shah, Svati H ^a   Arlotto, Michelle ^a   Slentz, Cris A ^a   Rochon, James ^a   Gallup, Dianne ^a   Ilkayeva, Olga ^a   Wenner, Brett R ^a   Yancy Jr , William S ^a   Eisenson, Howard ^a   Musante, Gerald ^a   Surwit, Richard S ^a   Millington, David S ^a   Butler, Mark D ^a   Svetkey, Laura P ^a   more..

^a DUKE UNIVERSITY MEDICAL CENTER   (United States)

Author keywords

HUMDISEASE

Indexed keywords

ACYLCARNITINE; BRANCHED CHAIN AMINO ACID; INSULIN RECEPTOR SUBSTRATE 1; MAMMALIAN TARGET OF RAPAMYCIN; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; RAPAMYCIN; STRESS ACTIVATED PROTEIN KINASE;

ADULT; AMINO ACID METABOLISM; ANIMAL EXPERIMENT; ANIMAL TISSUE; ARTICLE; CATABOLISM; CONTROLLED STUDY; ENZYME PHOSPHORYLATION; FEMALE; FOOD INTAKE; HUMAN; INSULIN RESISTANCE; LEAN BODY WEIGHT; LIPID DIET; MAJOR CLINICAL STUDY; MALE; METABOLIC BALANCE; METABOLOMICS; NONHUMAN; OBESITY; PRIORITY JOURNAL; RAT; WEIGHT GAIN;

ANIMALIA; RATTUS;

EID: 63449111894     PISSN: 15504131     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.cmet.2009.05.001     Document Type: Erratum

References (60)

1. An J., Muoio D.M., Shiota M., Fujimoto Y., Cline G.W., Shulman G.I., Koves T.R., Stevens R., Millington D., and Newgard C.B. Hepatic expression of malonyl-CoA decarboxylase reverses muscle, liver and whole-animal insulin resistance. Nat. Med. 10 (2004) 268-274
2. Ashley D.V.M., Fleury M.O., Golay A., Maeder E., and Leathwood P.D. Evidence for diminished brain 5-hydroxytryptamine biosynthesis in obese diabetic and non-diabetic humans. Am. J. Clin. Nutr. 42 (1985) 1240-1245
3. Bergman R.N., Phillips L.S., and Cobelli C. Physiologic evaluation of factors controlling glucose tolerance in man: measurement of insulin sensitivity and beta-cell glucose sensitivity from the response to intravenous glucose. J. Clin. Invest. 68 (1981) 1456-1467
4. Bjorbaek C., and Kahn B.B. Leptin signaling in the central nervous system and periphery. Recent Prog. Horm. Res. 59 (2004) 305-331
5. Breum L., Rasmussen M.H., Hilsted J., and Fernstrom J.D. Twenty-four hour plasma tryptophan concentrations and ratios are below normal in obese subjects and are not normalized by substantial weight reduction. Am. J. Clin. Nutr. 77 (2003) 1112-1118
6. Cao H., Gerhold K., Mayers J.R., Wiest M.M., Watkins S.M., and Hotamisligil G.S. Identification of a lipokine, a lipid hormone linking adipose tissue to systemic metabolism. Cell 134 (2008) 933-944
7. Capuron L., Ravaud A., Neveu P.J., Miller A.H., Maes M., and Dantzer R. Association between decreased serum tryptophan concentrations and depressive symptoms in cancer patients undergoing cytokine therapy. Mol. Psychiatry 7 (2002) 468-473
8. Chace D.H., Hillman S.L., Millington D.S., Kahler S.G., Roe C.R., and Naylor E.W. Rapid diagnosis of maple syrup urine disease in blood spots from newborns by tandem mass spectrometry. Clin. Chem. 41 (1995) 62-68
9. Chevalier S., Marliss E.B., Morais J.A., Lamarche M., and Gougeon R. Whole-body protein anabolic response is resistant to the action of insulin in obese women. Am. J. Clin. Nutr. 82 (2005) 355-365
10. Cota D., Proulx K., Smith K.A., Kozma S.C., Thomas G., Woods S.C., and Seeley R.J. Hypothalamic mTOR signaling regulates food intake. Science 312 (2006) 927-930
11. Craig C.L., Marshall A.L., Sjostrom M., Bauman A.E., Booth M.L., Ainsworth B.E., Pratt M., Ekelund U., Yngve A., Sallis J.F., and Oja P. International Physical Activity Questionnaire: 12-country reliability and validity. Med. Sci. Sports Exerc. 35 (2003) 1381-1395
12. Felig P., Wahren J., Hendler R., and Brundin T. Splanchnic glucose and amino acid metabolism in obesity. J. Clin. Invest. 53 (1974) 582-590
13. Fernstrom J.D. Branched-chain amino acids and brain function. J. Nutr. 135 (2005) 1539S-1546S
14. Ferrara C.T., Wang P., Neto E.C., Stevens R.D., Bain J.R., Wenner B.R., Ilkayeva O.R., Keller M.P., Blasiole D.A., Kendziorski C., et al. Genetic network of liver metabolism revealed by integration of metabolic and transcriptional profiling. PLoS Genet. 14 (2008) e1000034
15. Gougeon R., Morais J.A., Chevalier S., Pereira S., Lamarche M., and Marliss E.B. Determinants of whole-body protein metabolism in subjects with and without type 2 diabetes. Diabetes Care 231 (2008) 128-133
16. Haqq A.M., Lien L.F., Boan J., Arlotto M., Slentz C.A., Muehlbauer M.J., Rochon J., Gallup D., McMahon R.L., Bain J.R., et al. The Study of the Effects of Diet on Metabolism and Nutrition (STEDMAN) weight loss project: rationale and design. Contemp. Clin. Trials 26 (2005) 616-625
17. Harlan L.C., and Block G. Use of adjustment factors with a brief food frequency questionnaire to obtain nutrient values. Epidemiology 1 (1990) 224-231
18. He W., Lam T.K., Obici S., and Rossetti L. Molecular disruption of hypothalamic nutrient sensing induces obesity. Nat. Neurosci. 9 (2006) 227-233
19. Hedley A.A., Ogden C.L., Johnson C.L., Carroll M.D., Curtin L.R., and Flegal K.M. Prevalence of overweight and obesity among US children, adolescents, and adults, 1999-2002. JAMA 291 (2004) 2847-2850
20. Hiratani K., Haruta T., Tani A., Kawahara J., Usui I., and Kobayashi M. Role of mTOR and JNK in serine phosphorylation, translocation and degradation of IRS-1. Biochem. Biophys. Res. Commun. 30 (2005) 836-842
21. Hosoda H., Kojima M., and Kangawa K. Biological, physiological, and pharmacological aspects of ghrelin. J. Pharmacol. Sci. 100 (2006) 398-410
22. Houmard J.A., Tanner C.J., Yu C., Cunningham P.G., Poires W.J., MacDonald K.G., and Shulman G.I. Effect of weight loss on insulin sensitivity and intramuscular long-chain fatty acyl-CoAs in morbidly obese subjects. Diabetes 51 (2002) 2959-2963
23. Kahn S.E., Zinman B., Haffner S.M., O'Neill M.C., Kravitz B.G., Yu D., Freed M.I., Herman W.H., Holman R.R., Jones N.P., et al., ADOPT Study Group. Obesity is a major determinant of the association of C-reactive protein levels and the metabolic syndrome in type 2 diabetes. Diabetes 55 (2006) 2357-2364
24. Koves T.R., Ussher J.R., Noland R.C., Slentz D., Mosedale M., Ilkayeva O., Bain J., Stevens R., Dyck J.R., Newgard C.B., et al. Mitochondrial overload and incomplete fatty acid oxidation contribute to skeletal musle insulin resistance. Cell Metab. 7 (2008) 45-56
25. Krebs M., Krssak M., Bernroider E., Anderwald C., Brehm A., Meyerspeer M., Nowotny P., Roth E., Waldhausl W., and Roden M. Mechanism of amino acid-induced skeletal muscle insulin resistance in humans. Diabetes 51 (2002) 599-605
26. Krebs M., Brehm A., Krssak M., Anderwald C., Bernroider E., Nowotny P., Roth E., Chandramouli V., Landau B.R., Waldhausl W., and Roden M. Direct and indirect effects of amino acids on hepatic glucose metabolism in humans. Diabetologia 46 (2003) 917-925
27. Krebs M., Brunmair B., Brehm A., Artwohl M., Szendroedi J., Nowotny P., Roth E., Furnsinn C., Promintzer M., Anderwald C., et al. The mammalian target of rapamycin pathway regulates nutrient-sensitive glucose uptake in man. Diabetes 56 (2007) 1600-1607
28. Layman D.K., and Walker D.A. Potential importance of leucine in treatment of obesity and the metabolic syndrome. J. Nutr. 136 (2006) 319S-323S
29. Lepage G., and Roy C.C. Direct transesterification of all classes of lipids in a one-step reaction. J. Lipid Res. 27 (1986) 114-120
30. Maccario M., Ramunni J., Oleandri S.E., Procopio M., Grottoli S., Rossetto R., Savio P., Aimaretti G., Camanni F., and Ghigo E. Relationship bewteen IGF-1 and age, gender, body mass, fat distribution, metabolic and hormonal variables in obese patients. Int. J. Obes. Relat. Metab. Disord. 23 (1999) 612-618
31. Maccario M., Tassone F., Gauna C., Oleandri S.E., Aimaretti G., Procopio M., Grottoli S., Pflaum C.D., Stasburger C.J., and Ghigo E. Effects of short-term administration of low-dose rhGH on IGF-1 levels in obesity and Cushing's syndrome: indirect evaluation of sensitivity to GH. Eur. J. Endocrinol. 144 (2001) 251-256
32. Marin P., Kvist H., Lindstedt G., Sjostrom L., and Bjorntorp P. Low concentrations of insulin-like growth factor-1 in abdominal obesity. Int. J. Obes. Relat. Metab. Disord. 17 (1993) 83-89
33. McGarry J.D. Banting lecture 2001: dysregulation of fatty acid metabolism in the etiology of type 2 diabetes. Diabetes 51 (2002) 607-614
34. Millington D.S., Kodo N., Norwood D.L., and Roe C.R. Tandem mass spectrometry: a new method for acylcarnitine profiling with potential for neonatal screening for inborn errors of metabolism. J. Inherit. Metab. Dis. 13 (1990) 321-324
35. Morino K., Petersen K.F., and Shulman G.I. Molecular mechanisms of insulin resistance in humans and their potential links with mitochondrial dysfunction. Diabetes Suppl. 2 (2006) S9-S15
36. Muoio D.M., and Newgard C.B. Molecular and metabolic mechanisms of insulin resistance and β-cell failure in type 2 diabetes. Nat. Rev. Mol. Cell Biol. 9 (2008) 193-205
37. Mussig K., Fiedler H., Staiger H., Weigert C., Lehmann R., Schleicher E.D., and Haring H.U. Insulin-induced stimulation of JNK and the PI 3-kinase/mTOR pathway leads to phosphorylation of serine 318 or IRS-1 in C2C12 myocytes. Biochem. Biophys. Res. Commun. 335 (2005) 819-825
38. Newgard C.B., and Matschinsky F.M. Substrate control in insulin release. In: Jefferson J., and Cherrington A. (Eds). Handbook of Physiology (2001), Oxford University Press, Oxford 125-152
39. Patterson B.W., Zhao G., Elias N., Hachey D.L., and Klein S. Validation of a new procedure to determine plasma fatty acid concentration and isotopic enrichment. J. Lipid Res. 40 (1999) 2118-2124
40. Pereira S., Marliss E.B., Morais J.A., Chevalier S., and Gougeon R. Insulin resistance of protein metabolism in type 2 diabetes. Diabetes 57 (2008) 56-63
41. Pocai A., Lam T.K., Obici S., Gutierrez-Juarez R., Muse E.D., Arduini A., and Rossetti L. Restoration of hypothalamic lipid sensing normalizes energy and glucose homeostasis in overfed rats. J. Clin. Invest. 116 (2006) 1081-1091
42. Rasmussen M.H., Frystyk J., Andersen T., Breum L., Christiansen J.S., and Hilsted J. The impact of obesity, fat distribution, and energy restriction on insulin-like growth factor-1, IGF binding protein-3, insulin, and growth hormone. Metabolism 43 (1994) 315-319
43. Reaven G.M. The metabolic syndrome: is this diagnosis necessary?. Am. J. Clin. Nutr. 83 (2006) 1237-1247
44. Ridker P.M., Buring J.E., Shih J., Matias M., and Hennekens C.H. Prospective study of C-reactive protein and the risk of future cardiovascular events among apparently healthy women. Circulation 98 (1998) 731-733
45. Scacchi M., Pincelli A., and Cavagnini F. Growth hormone in obesity. Int. J. Obes. 23 (1999) 260-271
46. Schneider H.J., Saller B., Kotsche J., Marz W., Erwa W., Wittchen H.-U., and Stalla G.K. Opposite associations of age-dependent insulin-like growth factor-I standard deviation scores with nutritional state in normal weight and obese subjects. Eur. J. Endocrinol. 154 (2006) 699-706
47. She P., Reid T.M., Bronson S.K., Vary T.C., Hajnal A., Lynch C.J., and Hutson S.M. Disruption of BCATm in mice leads to increased energy expenditure associated with activation of a futile protein turnover cycle. Cell Metab. 6 (2007) 181-194
48. Shoelson S.E., Lee J., and Goldfine A.B. Inflammation and insulin resistance. J. Clin. Invest. 116 (2006) 1793-1801
49. Sowers J.R. Obesity as a cardiovascular risk factor. Am. J. Med. 115 Suppl 8A (2003) 37S-41S
50. Summers S.A. Ceramides in insulin resistance and lipotoxicity. Prog. Lipid Res. 45 (2006) 42-72
51. Tischler M.E., Desautels M., and Goldberg A.L. Does leucine, leucyl-tRNA, or some metabolite of leucine regulate protein synthesis and degradation in skeletal and cardiac muscle?. J. Biol. Chem. 257 (1982) 1613-1621
52. Tremblay F., Krebs M., Dombrowski L., Brehm A., Bernroider E., Roth E., Nowotny P., Waldhausl W., Marette A., and Roden M. Overactivation of S6 kinase 1 as a cause of human insulin resistance during increased amino acid availability. Diabetes 54 (2005) 2674-2684
53. Tremblay F., Brule S., Um S.H., Li Y., Masuda K., Roden M., Sun X.J., Krebs M., Polakiewicz R.D., Thomas G., and Marette A. Identification of IRS-1 Ser-1101 as a target of S6K1 in nutrient- and obesity-induced insulin resistance. Proc. Natl. Acad. Sci. USA 104 (2007) 14056-14061
54. Tremblay F., Lavigne C., Jacques H., and Marette A. Role of dietary proteins and amino acids in the pathogenesis of insulin resistance. Annu. Rev. Nutr. 27 (2007) 293-310
55. Trujillo M.E., and Scherer P.E. Adipose tissue-derived factors: impact on health and disease. Endocr. Rev. 27 (2006) 762-778
56. Um S.H., D'Alessio D., and Thomas G. Nutrient overload, insulin resistance and ribosomal protein S6 kinase 1, D6K1. Cell Metab. 3 (2006) 393-402
57. Wellen K.E., and Hotamisligil G.S. Inflammation, stress, and diabetes. J. Clin. Invest. 115 (2005) 1111-1119
58. Wittchen H.U., Glaesmer H., Marz W., Stalla G.K., Lennert H., Zeiher A.M., Silber S., Koch U., Boher S., Pittrow D., Ruf G., and DETECT Study Group. Cardiovascular risk factors in primary care patients: methods and baseline prevalence results from the DETECT program. Curr. Med. Res. Opin. 12 (2005) 619-629
59. Wu J.Y., Kao H.J., Li S.C., Stevens R., Hillman S., Millington D., and Chen Y.T. ENU mutagenesis identifies mice with mitochondrial branched-chain aminotransferase deficiency resembling human maple syrup urine disease. J. Clin. Invest. 113 (2004) 434-440
60. Zhang Y., Guo K., LeBlanc R.E., Loh D., Schwartz G.J., and Yu Y.-H. Increasing dietary leucine intake reduces diet-induced obesity and improves glucose and cholesterol metabolism in mice via multimechanisms. Diabetes 56 (2007) 1647-1654